Zimmer Biomet (ZBH) FY2024 10-K Annual Report
Zimmer Biomet (ZBH) 10-K annual report for fiscal year 2024, filed with SEC EDGAR on Feb 25, 2025. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.
Zimmer Biomet FY2024 10-K Analysis
Business Overview
- • Core business model: Medical device design, manufacture, and distribution focused on orthopedic products
- • No new products, services, or segments introduced or emphasized this year
Zimmer Biomet FY2024 Key Financial MetricsXBRL
Revenue
$7.7B
▲ +3.8% YoY
Net Income
$904M
▼ -11.7% YoY
Operating Margin
16.7%
▼ -54bp YoY
Net Margin
11.8%
▼ -208bp YoY
ROE
7.2%
▼ -96bp YoY
Total Assets
$21.4B
▼ -0.6% YoY
EPS (Diluted)
$4.43
▼ -9.2% YoY
Operating Cash Flow
$1.5B
▼ -5.2% YoY
Source: XBRL data from Zimmer Biomet FY2024 10-K filing on SEC EDGAR. All figures in USD.
Other Zimmer Biomet Annual Reports
Get deeper insights on Zimmer Biomet
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.